# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-082792
Filing Date
2026-07-29
Accepted
2026-07-29 16:05:47
Documents
8
Period of Report
2026-07-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea0299567-6k_purple.htm | 6-K | 15472
2 | NOTICE AND PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS OF PUR | ea029956701ex99-1.htm | EX-99.1 | 320116
3 | VOTING SLIP FOR HOLDERS OF ORDINARY SHARES | ea029956701ex99-2.htm | EX-99.2 | 20318
4 | BNY MELLON VOTING INSTRUCTION FORM FOR HOLDERS OF AMERICAN DEPOSITARY SHARES | ea029956701ex99-3.htm | EX-99.3 | 5386
5 | GRAPHIC | ea029956701_ex99-1img1.jpg | GRAPHIC | 1934
6 | GRAPHIC | ea029956701_ex99-2img1.jpg | GRAPHIC | 1934
7 | GRAPHIC | ea029956701_ex99-3img1.jpg | GRAPHIC | 582921
8 | GRAPHIC | ea029956701_ex99-3img2.jpg | GRAPHIC | 339621
| Complete submission text file | 0001213900-26-082792.txt |  | 1638884

Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 261217371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)